Navigation Links
Heartburn Sufferers Find Lasting Relief With TUMS(R) Dual Action

One tablet goes to work in seconds to relieve heartburn all day or all night

PITTSBURGH, April 8 /PRNewswire/ -- Approximately 60 million Americans experience heartburn at least once a month. For those sufferers whose occasional heartburn gets in the way of life, TUMS(R), the best selling antacid in America, is introducing a new, long-lasting treatment. TUMS Dual Action, just like all TUMS, goes to work in seconds but also lasts for hours -- all day or all night -- offering heartburn sufferers long-lasting relief without compromise.


TUMS Dual Action contains calcium carbonate, the same trusted ingredient as the regular TUMS that Americans have depended upon for the past 75 years. TUMS Dual Action also includes an additional antacid ingredient, magnesium hydroxide, and 10 mg of famotidine, a safe and effective acid reducer, to help keep heartburn from coming back, making it the longest lasting TUMS ever. Available in Berry or Mint flavor, the one-dose chewable tablet immediately neutralizes acid on contact. Like all TUMS, it is also an excellent source of calcium, with 320 mg of elemental calcium per tablet.

"TUMS Dual Action is a natural extension for the iconic TUMS brand, offering a proven solution for occasional heartburn sufferers looking for long-lasting relief from a trusted source," says Jack Levy, TUMS Brand Manager at GlaxoSmithKline Consumer Healthcare. "With it, heartburn sufferers won't need to think about whether or not lunchtime heartburn will interrupt dinner, or whether they'll be able to sleep without being bothered by heartburn."

A Perfect Partner when Heartburn Breaks Through

In addition to providing relief to occasional heartburn sufferers, TUMS Dual Action can also help patients who experience breakthrough heartburn while taking other medications like proton pump inhibitors (PPIs). Despite high compliance with PPIs, the group of prescription heartburn drugs that reduce stomach acid production, 46% or more of PPI users experience breakthrough heartburn, or episodes of heartburn between doses, often at night. TUMS Dual Action can safely be taken to provide relief from breakthrough heartburn when used as directed.

TUMS Dual Action is currently available nationwide at drug, grocery and mass merchandise stores in both Berry and Mint flavors. The expected retail price for a 25-dose bottle is $8.99, and a 50-dose bottle is $15.49. Through May 15, consumers also have the opportunity to play an instant-win trivia game at The virtual multiple-choice quiz asks consumers general questions about heartburn-inducing foods, and gives participants the opportunity to win one of 400 instant-win "dinner and a movie" prizes consisting of a $25 gift card for Movie Cash or Fandango and a $25 gift card to Brinker Restaurants (Chili's Grill & Bar, Romano's Macaroni Grill, On the Border Mexican Grill & Cantina or Maggiano's Little Italy). All players will be entered into a sweepstakes to win a grand prize weekend getaway to San Francisco, Chicago or New York.

For more information, to download a $3 TUMS Dual Action coupon and for official sweepstakes rules, please visit

About TUMS(R)

For more than 75 years, TUMS(R) has been a fast, effective treatment for heartburn and acid indigestion, neutralizing stomach acid on contact. Today, TUMS is the number one antacid in America, used by more people than any other brand to treat heartburn.

About GlaxoSmithKline Consumer Healthcare

GlaxoSmithKline Consumer Healthcare is one of the world's largest over-the-counter consumer healthcare products companies. Its more than 30 well-known brands include the leading smoking cessation products, Nicorette(R) and NicoDerm(R), as well as many medicine cabinet staples, alli(R), Aquafresh(R), Sensodyne(R) and TUMS(R), which are trademarks owned by and/or licensed to GlaxoSmithKline Group of Companies.

About GlaxoSmithKline

GlaxoSmithKline -- one of the world's leading research-based pharmaceutical and healthcare companies -- is committed to improving the quality of human life by enabling people to do more, feel better and live longer.

SOURCE GlaxoSmithKline Consumer Healthcare
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Blood Thinner, Heartburn Drugs May Be Risky After Heart Attack
2. Plavix Plus Heartburn Drugs May Hike Heart Risk
3. CHPA, Nielsen: OTC Heartburn Therapy Saves Nearly $800 Million Annually, Vast Majority of OTC Heartburn Consumers Satisfied
4. Survey Reveals Heartburn Sufferers Experience More Heartburn During the Holidays
5. First Over-The-Counter Store Brand Omeprazole Offering in U.S. Market Creates New Option for Frequent Heartburn Sufferers
6. AUDIO from Medialink and Prilosec OTC: Recipes for Heartburn-Friendly Super Bowl Snacking
7. FDA Confirms No Heart Risk From Heartburn Drugs
8. Survey Reveals Heartburn Sufferers Experience More Heartburn During the Holidays
9. Heartburn Can Be a Sign of Serious Disease
10. Chronic Pain Sufferers Report Relief: DRJ Group Teams With Adult Foster Care Facilities to Evaluate Effectiveness of Stopain Topical Analgesic
11. Actress and Mom Alison Sweeney Teams Up With the American Pharmacists Association to Help Fellow Allergy Sufferers Find Relief This Spring
Post Your Comments:
(Date:11/30/2015)... ... November 30, 2015 , ... An inventor from Charlottesville, ... the womb. "My last baby had high blood pressure due to loud noises," she ... protect their babies from noise pollution as well as radio waves and microwaves." , ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... automated breast density assessment and enterprise analytics solutions, here at the 101st ... (South Hall booth #2377). Volpara’s quantitative breast imaging tools enable personalized measurements ...
(Date:11/30/2015)... , ... November 30, 2015 , ... ... – Kreithen”), one of the leading plastic surgery practices in Florida, is proud ... chosen to consult for surgical innovations giant Ethicon Inc., a Johnson & Johnson ...
(Date:11/30/2015)... Morton Grove, IL (PRWEB) , ... November 30, 2015 , ... ... milestone for an emerging pharmaceutical company. Because it is so important to this key ... titled “Success Factors in your IND Filing” on December 4th at 11am EST. , ...
(Date:11/30/2015)... ... 30, 2015 , ... Healthjump, Inc. announced that it has ... consulting, development and support company. The purchase will expand the capability to serve ... extend the services currently provided by Healthjump. , Through this purchase, ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... BOSTON , Nov. 30, 2015  Kevin ... of Sensium Healthcare, a global pioneer in wireless ... Boston, MA , Mr. Smith ... of Sensium,s global commercial strategy.  He will also ... universities, to build clinical evidence for SensiumVitals, the ...
(Date:11/30/2015)... , Nov. 30, 2015  The fee-for-service ... in U.S. medical imaging is on its ... accountable care payer-provider contracts are set to ... their wake, alter provider-vendor relationships. The shift ... push forward new purchasing frameworks in the ...
(Date:11/30/2015)... WOODCLIFF LAKE, N.J. and SAN ... Inc. and Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) ... (FDA) has accepted for filing the New Drug Application ... approved, the extended release formulation will offer patients a ... ® ) is currently approved as ...
Breaking Medicine Technology: